Jason Fredette, IRC, is an award-winning investor relations professional with more than 15 years of experience raising and enhancing the profile of public companies. Jason currently serves as Senior Director of Investor Relations and Corporate Communications at Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biopharmaceutical company.
Before joining Selecta, he led investor relations, public relations and corporate marketing for Chiasma, Inc., Select Income REIT, Government Properties Income Trust and American Superconductor Corporation. Jason began his career in investor relations serving clients in a broad range of industries at Sharon Merrill Associates (SMA), a nationally recognized investor relations and corporate communications strategic advisory firm.
He has been recognized by Institutional Investor Magazine in its Best Investor Relations Professional listings, and his work was integral to SMA’s attainment of three Publicity Club of New England Bell Ringer Awards during his agency tenure.
Jason earned a bachelor’s degree in mass communications from Westfield State University.